253 related articles for article (PubMed ID: 34837627)
1. Multiple microRNA signature panel as promising potential for diagnosis and prognosis of head and neck cancer.
Subha ST; Chin JW; Cheah YK; Mohtarrudin N; Saidi HI
Mol Biol Rep; 2022 Feb; 49(2):1501-1511. PubMed ID: 34837627
[TBL] [Abstract][Full Text] [Related]
2. Salivary microRNA miR-let-7a-5p and miR-3928 could be used as potential diagnostic bio-markers for head and neck squamous cell carcinoma.
Fadhil RS; Wei MQ; Nikolarakos D; Good D; Nair RG
PLoS One; 2020; 15(3):e0221779. PubMed ID: 32208417
[TBL] [Abstract][Full Text] [Related]
3. Prognostic microRNA signatures derived from The Cancer Genome Atlas for head and neck squamous cell carcinomas.
Wong N; Khwaja SS; Baker CM; Gay HA; Thorstad WL; Daly MD; Lewis JS; Wang X
Cancer Med; 2016 Jul; 5(7):1619-28. PubMed ID: 27109697
[TBL] [Abstract][Full Text] [Related]
4. A robust six-miRNA prognostic signature for head and neck squamous cell carcinoma.
Zhao X; Cui L
J Cell Physiol; 2020 Nov; 235(11):8799-8811. PubMed ID: 32342519
[TBL] [Abstract][Full Text] [Related]
5. Deep sequencing-based microRNA expression signatures in head and neck squamous cell carcinoma: dual strands of pre-miR-150 as antitumor miRNAs.
Koshizuka K; Nohata N; Hanazawa T; Kikkawa N; Arai T; Okato A; Fukumoto I; Katada K; Okamoto Y; Seki N
Oncotarget; 2017 May; 8(18):30288-30304. PubMed ID: 28415821
[TBL] [Abstract][Full Text] [Related]
6. MicroRNAs as new biomarkers for human papilloma virus related head and neck cancers.
Wang Y; Wang J; Huang Y
Cancer Biomark; 2015; 15(3):213-8. PubMed ID: 25769448
[TBL] [Abstract][Full Text] [Related]
7. Excavating novel diagnostic and prognostic long non-coding RNAs (lncRNAs) for head and neck squamous cell carcinoma: an integrated bioinformatics analysis of competing endogenous RNAs (ceRNAs) and gene co-expression networks.
Yang L; Lu P; Yang X; Li K; Chen X; Qu S
Bioengineered; 2021 Dec; 12(2):12821-12838. PubMed ID: 34898376
[TBL] [Abstract][Full Text] [Related]
8. Role of miRNA in head and neck squamous cell carcinoma.
Masood Y; Kqueen CY; Rajadurai P
Expert Rev Anticancer Ther; 2015 Feb; 15(2):183-97. PubMed ID: 25367254
[TBL] [Abstract][Full Text] [Related]
9. Salivary MicroRNAs for Early Detection of Head and Neck Squamous Cell Carcinoma: A Case-Control Study in the High Altitude Mestizo Ecuadorian Population.
Salazar-Ruales C; Arguello JV; López-Cortés A; Cabrera-Andrade A; García-Cárdenas JM; Guevara-Ramírez P; Peralta P; Leone PE; Paz-Y-Miño C
Biomed Res Int; 2018; 2018():9792730. PubMed ID: 30584540
[TBL] [Abstract][Full Text] [Related]
10. Altered peritumoral microRNA expression predicts head and neck cancer patients with a high risk of recurrence.
Ganci F; Sacconi A; Manciocco V; Covello R; Benevolo M; Rollo F; Strano S; Valsoni S; Bicciato S; Spriano G; Muti P; Fontemaggi G; Blandino G
Mod Pathol; 2017 Oct; 30(10):1387-1401. PubMed ID: 28731048
[TBL] [Abstract][Full Text] [Related]
11. The role of miRNAs in human papilloma virus (HPV)-associated cancers: bridging between HPV-related head and neck cancer and cervical cancer.
Lajer CB; Garnæs E; Friis-Hansen L; Norrild B; Therkildsen MH; Glud M; Rossing M; Lajer H; Svane D; Skotte L; Specht L; Buchwald C; Nielsen FC
Br J Cancer; 2012 Apr; 106(9):1526-34. PubMed ID: 22472886
[TBL] [Abstract][Full Text] [Related]
12. Immune-related miRNA signature identifies prognosis and immune landscape in head and neck squamous cell carcinomas.
Ma B; Li H; Qiao J; Meng T; Yu R
Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33111959
[TBL] [Abstract][Full Text] [Related]
13. Antitumor miR-150-5p and miR-150-3p inhibit cancer cell aggressiveness by targeting SPOCK1 in head and neck squamous cell carcinoma.
Koshizuka K; Hanazawa T; Kikkawa N; Katada K; Okato A; Arai T; Idichi T; Osako Y; Okamoto Y; Seki N
Auris Nasus Larynx; 2018 Aug; 45(4):854-865. PubMed ID: 29233721
[TBL] [Abstract][Full Text] [Related]
14. Circulating microRNAs as novel prognosis biomarkers for head and neck squamous cell carcinoma.
Hou B; Ishinaga H; Midorikawa K; Shah SA; Nakamura S; Hiraku Y; Oikawa S; Murata M; Takeuchi K
Cancer Biol Ther; 2015; 16(7):1042-6. PubMed ID: 25950115
[TBL] [Abstract][Full Text] [Related]
15. Two miRNA prognostic signatures of head and neck squamous cell carcinoma: A bioinformatic analysis based on the TCGA dataset.
Wu C; Tong L; Wu C; Chen D; Chen J; Li Q; Jia F; Huang Z
Cancer Med; 2020 Apr; 9(8):2631-2642. PubMed ID: 32064753
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA expression profile in head and neck cancer: HOX-cluster embedded microRNA-196a and microRNA-10b dysregulation implicated in cell proliferation.
Severino P; Brüggemann H; Andreghetto FM; Camps C; Klingbeil Mde F; de Pereira WO; Soares RM; Moyses R; Wünsch-Filho V; Mathor MB; Nunes FD; Ragoussis J; Tajara EH
BMC Cancer; 2013 Nov; 13():533. PubMed ID: 24209638
[TBL] [Abstract][Full Text] [Related]
17. microRNAs deregulation in head and neck squamous cell carcinoma.
Carron J; Torricelli C; Silva JK; Queiroz GSR; Ortega MM; Lima CSP; Lourenço GJ
Head Neck; 2021 Feb; 43(2):645-667. PubMed ID: 33159410
[TBL] [Abstract][Full Text] [Related]
18. Identification of a six microRNA signature as a novel potential prognostic biomarker in patients with head and neck squamous cell carcinoma.
Shi H; Chen J; Li Y; Li G; Zhong R; Du D; Meng R; Kong W; Lu M
Oncotarget; 2016 Apr; 7(16):21579-90. PubMed ID: 26933913
[TBL] [Abstract][Full Text] [Related]
19. Cross validated serum small extracellular vesicle microRNAs for the detection of oropharyngeal squamous cell carcinoma.
Mayne GC; Woods CM; Dharmawardana N; Wang T; Krishnan S; Hodge JC; Foreman A; Boase S; Carney AS; Sigston EAW; Watson DI; Ooi EH; Hussey DJ
J Transl Med; 2020 Jul; 18(1):280. PubMed ID: 32650803
[TBL] [Abstract][Full Text] [Related]
20. A novel saliva-based microRNA biomarker panel to detect head and neck cancers.
Salazar C; Nagadia R; Pandit P; Cooper-White J; Banerjee N; Dimitrova N; Coman WB; Punyadeera C
Cell Oncol (Dordr); 2014 Oct; 37(5):331-8. PubMed ID: 25156495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
